Clinical Trials Directory

Trials / Completed

CompletedNCT02255084

Vaginal Self-sampling and Human Papillomavirus Testing in Unscreened Women

Attitude of Unscreened Women Face to Different Strategies to Participate in Cervical Cancer Screening by Vaginal Self-sampling : Home-mailed or Invitation to Remove to Their General Practitioner

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,612 (actual)
Sponsor
University Hospital, Tours · Academic / Other
Sex
Female
Age
30 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Despite the existence of an effective screening test (pap smear), cervical cancer is, every year in France, the cause of more than 3,000 new cases and 1,100 deaths. But, in France, 4 in 10 women are not screened or not often enough (nearly 7 millions women). It is therefore necessary to develop new strategies to reach these women. The etiological factor of this cancer is persistent infection with High-Risk Human PapillomaVirus oncogene (HR-HPV). Thereby, HPV-based tests could be alternative screening tests. Vaginal self-sampling with HR-HPV test is simpler and less intrusive than the pap smear. It has been shown that vaginal self-sampling with HPV test is a powerful means to increase the participation rate in cervical cancer screening.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGroup 1 remove self sample kit at gp consulting room or perform pap smearSelected general practitioners are briefly informed about the study and they receive a package of kits for vaginal self-sampling. Selected women receive a mail inviting them either to remove a kit for vaginal self-sampling at their general practitioner's consulting room or to perform a pap smear. When women choose the vaginal self-sampling, a HPV test is performed on the sample in a virology laboratory.
BEHAVIORALGroup 2 perform self sample at home or pap smearSelected general practitioners are briefly informed about the study. Selected women receive a mail inviting them either to perform a vaginal self sampling at their home (with the kit provided) or to perform a pap smear. When women choose the vaginal self-sampling, a HPV test is performed on the sample in a virology laboratory.

Timeline

Start date
2015-02-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2014-10-02
Last updated
2025-12-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02255084. Inclusion in this directory is not an endorsement.